Apostrophe was a phone-based teledermatology service for personalized prescription acne treatment. Hims & Hers shut it down on March 7, 2025, according to Fierce Healthcare in the Fierce Healthcare shutdown report, so 2026 readers need options and safety steps. This guide summarizes what Apostrophe offered and what former users can do now. It focuses on treatments with dermatology guideline support and practical transfer steps.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What happened to Apostrophe?
- How did Apostrophe treat acne?
- Which acne treatments have strong support?
- What safety issues matter most?
- How do you continue care after closure?
What happened to Apostrophe?
Fierce Healthcare reported that Hims & Hers discontinued Apostrophe to favor its own dermatology offerings. Active subscriptions were canceled at shutdown.
Patients had about 30 days before provider-team and account access ended. This closure hit active acne-treatment subscribers who relied on ongoing refills. Honeydew Dermatology notes former users must transfer prescriptions and re-establish care elsewhere.
How did Apostrophe treat acne?
TechCrunch described Apostrophe as connecting users with board-certified dermatologists by phone and photo visit. Those doctors wrote personalized prescription plans.
A vertically integrated mail-order pharmacy dispensed the drugs. Honeydew Dermatology described the acne formulary as combining custom topical tretinoin, clindamycin, azelaic acid, spironolactone and similar agents with oral drugs. Options included oral antibiotics and isotretinoin for moderate-to-severe cases.
Which acne treatments have strong support?
Readers comparing old Apostrophe formulas to current care should start with guideline-backed ingredients. American Academy of Dermatology 2024 guidelines strongly recommend benzoyl peroxide, tretinoin-type retinoids, antibiotics including doxycycline, and isotretinoin for severe acne, as detailed in the American Academy of Dermatology guideline summary.
That overlap explains why former Apostrophe prescriptions often look familiar to a new dermatologist. Bring the full ingredient list to help match effective parts without restarting from zero.
What safety issues matter most?
Topical tretinoin can cause irritation, peeling, and heightened sun sensitivity, according to the National Library of Medicine DailyMed FDA label in the DailyMed FDA label for topical tretinoin. The same label directs minimizing sunlight and sunlamps, using sunscreen and protective clothing, and avoiding use on sunburned or eczematous skin.
Oral isotretinoin treats severe recalcitrant nodular acne but is highly teratogenic. The FDA makes it available only under the restricted iPLEDGE risk-management program to prevent fetal exposure, as explained in the FDA isotretinoin safety page.
- Pause tretinoin on sunburned, peeling, or eczema-affected skin and ask a clinician before restarting.
- Use daily sunscreen, limit midday sun, and wear a hat and protective clothing during tretinoin treatment.
- Tell your care team right away about possible pregnancy, planned pregnancy, or missed birth-control doses on isotretinoin.
How do you continue care after closure?
Request your records, active prescriptions, and ingredient strengths before account access closes. Book a dermatologist, urgent-care clinic, or primary-care clinician to review refills. Bring photos of progress, side effects, and any lab history.
Honeydew Dermatology notes photo-only teledermatology cannot replace in-person evaluation plus required pregnancy testing, labs, and iPLEDGE monitoring for isotretinoin. Expect an in-person visit, pregnancy test when applicable, and follow-up labs for higher-risk oral treatment. Keep a copy of your last Apostrophe ingredient list until the new plan is stable.
- List every topical and oral product, strength, frequency, start date, and response.
- Ask whether each guideline-backed ingredient should continue, change, or stop.
- Confirm refill transfer, monitoring plan, and sun-protection steps in writing.